Targeted therapies: Biomarkers in NSCLC for selecting cetuximab therapy
- PMID: 20668478
- DOI: 10.1038/nrclinonc.2010.99
Targeted therapies: Biomarkers in NSCLC for selecting cetuximab therapy
Similar articles
-
Ramucirumab combination improves OS and PFS in NSCLC.Am J Manag Care. 2014 Mar;20(5 Spec No.):E9. Am J Manag Care. 2014. PMID: 25618624 No abstract available.
-
Cetuximab in non-small cell lung cancer.Expert Opin Biol Ther. 2008 Jan;8(1):107-13. doi: 10.1517/14712598.8.1.107. Expert Opin Biol Ther. 2008. PMID: 18081540 Review.
-
[Promising targeted molecular therapies for the future years in non-small-cell lung cancer].Rev Pneumol Clin. 2006 Feb;62 Spec no 1:1S35-6. Rev Pneumol Clin. 2006. PMID: 16719155 French. No abstract available.
-
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.Cancer. 2009 Apr 15;115(8):1713-22. doi: 10.1002/cncr.24148. Cancer. 2009. PMID: 19208430 Free PMC article. Clinical Trial.
-
Medical treatment of non-small-cell lung cancer.Ann Oncol. 2005;16 Suppl 2:ii229-32. doi: 10.1093/annonc/mdi721. Ann Oncol. 2005. PMID: 15958463 Review. No abstract available.
Cited by
-
Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.Mol Oncol. 2014 May;8(3):620-32. doi: 10.1016/j.molonc.2014.01.006. Epub 2014 Jan 22. Mol Oncol. 2014. PMID: 24508062 Free PMC article.
-
Prognostic value of LIPC in non-small cell lung carcinoma.Cell Cycle. 2013 Feb 15;12(4):647-54. doi: 10.4161/cc.23517. Epub 2013 Jan 23. Cell Cycle. 2013. PMID: 23343765 Free PMC article.
-
DNA Molecular Computing with Weighted Signal Amplification for Cancer miRNA Biomarker Diagnostics.Adv Sci (Weinh). 2025 Jun;12(22):e2416490. doi: 10.1002/advs.202416490. Epub 2025 Apr 11. Adv Sci (Weinh). 2025. PMID: 40213938 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous